These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 11709406
1. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Leenen FH, White R, Yuan B. Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406 [Abstract] [Full Text] [Related]
2. Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossoni LV, Frimm C, Anéas I, Negrão CE, Krieger JE, Oliveira EM. Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3575-83. PubMed ID: 17906098 [Abstract] [Full Text] [Related]
3. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Ruzicka M, Yuan B, Harmsen E, Leenen FH. Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912 [Abstract] [Full Text] [Related]
4. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Brown NJ, Agirbasli M, Vaughan DE. Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455 [Abstract] [Full Text] [Related]
5. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, Ogihara T. Hypertension; 1992 Jun; 19(6 Pt 2):708-12. PubMed ID: 1534315 [Abstract] [Full Text] [Related]
6. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Leenen FH, Skarda V, Yuan B, White R. Am J Physiol; 1999 Jan; 276(1):H317-25. PubMed ID: 9887046 [Abstract] [Full Text] [Related]
7. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload. Ishiye M, Umemura K, Uematsu T, Nakashima M. Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986 [Abstract] [Full Text] [Related]
8. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Zolk O, Flesch M, Schnabel P, Teisman AC, Pinto YM, van Gilst WH, Paul M, Böhm M. Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380 [Abstract] [Full Text] [Related]
9. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake. Zhao X, White R, Van Huysse J, Leenen FH. J Hypertens; 2000 Sep; 18(9):1319-26. PubMed ID: 10994763 [Abstract] [Full Text] [Related]
10. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure. Kawai H, Stevens SY, Liang CS. Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3012-9. PubMed ID: 11087259 [Abstract] [Full Text] [Related]
11. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy. Mukawa H, Toki Y, Shimauchi A, Matsui H, Morishima I, Okumura K, Ito T, Hayakawa T. J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751 [Abstract] [Full Text] [Related]
12. The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin. Ruzicka M, Keeley FW, Leenen FH. Circulation; 1994 Oct; 90(4):1989-96. PubMed ID: 7923689 [Abstract] [Full Text] [Related]
13. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Makino N, Sugano M, Otsuka S, Hata T. Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375 [Abstract] [Full Text] [Related]
14. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Ruzicka M, Skarda V, Leenen FH. Circulation; 1995 Dec 15; 92(12):3568-73. PubMed ID: 8521580 [Abstract] [Full Text] [Related]
15. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. Teisman AC, Pinto YM, Buikema H, Flesch M, Böhm M, Paul M, van Gilst WH. J Hypertens; 1998 Dec 15; 16(12 Pt 1):1759-65. PubMed ID: 9869009 [Abstract] [Full Text] [Related]
16. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Hu K, Gaudron P, Anders HJ, Weidemann F, Turschner O, Nahrendorf M, Ertl G. Cardiovasc Res; 1998 Aug 15; 39(2):401-12. PubMed ID: 9798525 [Abstract] [Full Text] [Related]
17. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Haddad G, Amiri F, Garcia R. Regul Pept; 1997 Jan 29; 68(2):111-7. PubMed ID: 9110382 [Abstract] [Full Text] [Related]
18. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system. Nagata S, Kato J, Kuwasako K, Asami M, Kitamura K. Hypertens Res; 2012 Feb 29; 35(2):234-8. PubMed ID: 21993212 [Abstract] [Full Text] [Related]
19. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC. Kidney Int; 2005 Nov 29; 68(5):2189-96. PubMed ID: 16221218 [Abstract] [Full Text] [Related]
20. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Lear W, Ruzicka M, Leenen FH. Am J Physiol; 1997 Aug 29; 273(2 Pt 2):H641-6. PubMed ID: 9277479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]